HIV group | Control group | Odds Ratio (HIV group / Control group) | Odds Ratio 95% Confidence Interval | Significance | |
---|---|---|---|---|---|
Post operative variables (Incidence percentage) | |||||
Mortality | 0 | 0 | ** | ** | ** |
Acute renal failure* | 6.4% | 0.5% | 13.821 | [1.791, 106.673] | p = 0.01 |
Myocardial infarction | 0% | 0% | ** | ** | ** |
Blood loss anemia | 16.7% | 9.9% | 1.841 | [1.020, 3.323] | p = 0.041 |
Pneumonia | 0.5% | 0 | 0.499 | [0.452, 0.550] | p = 0.499 |
Pulmonary embolism | 0.5% | 1% | 0.498 | [0.045, 5.530] | p = 0.562 |
Deep vein thrombosis | 0.5% | 0.5% | 1 | [0.062, 16.097] | p = 1.000 |
Periprosthetic fracture | 1% | 1% | 1 | [0.139, 7.168] | p = 1.000 |
Periprosthetic dislocation | 1% | 0.5% | 2.010 | [0.181, 22.343] | p = 0.562 |
Periprosthetic mechanical complication | 1.5% | 0% | 0.496 | [0.450, 0.548] | p = 0.082 |
Periprosthetic infection | 3% | 1% | 3.061 | [0.610, 15.349] | p = 0.153 |
Superficial surgical site infection | 0% | 0% | ** | ** | ** |
Deep surgical site infection | 0% | 0% | ** | ** | ** |
Wound dehiscence | 0.5% | 0.5% | 1 | [0.062, 16.097] | p = 1 |
Cardiac arrest and ventricular fibrillation | 0% | 0% | ** | ** | ** |
Blood transfusion* | 3.9% | 0.5% | 8.287 | [1.027, 66.827] | p = 0.018 |